We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Latest Industry Insights

Protein structure.
Industry Insight

Expanding the Drug Target Universe: How Next-Generation Proteomics Is Transforming Oncology Research

Cutting-edge mass spectrometry proteomics technologies are accelerating the discovery and validation of novel targets in cancer, opening up new avenues for next-generation cancer therapeutics.
Cancer patient with a line in her arm talking to a medic with a stethoscope around her neck.
Industry Insight

Next-Generation Proteomics Solutions Set To Accelerate Targeted Therapies

Hear how the capabilities of mass spectrometry (MS)-based proteomics are proving themselves in drug development and discovery and what this means for those working in oncology.
A picture of medicines.
Industry Insight

Failing Faster To Succeed Sooner in Drug Discovery

Revvity announced its newly established Scientific Centre of Excellence in Cambridge, where scientists can outsource their research needs to Revvity experts. Technology Networks visited the site to learn more about how Revvity is supporting its customers in their drug discovery efforts.
DNA double helix on a blue background.
Industry Insight

You Have No Moat – The Great AI Democratization Spells New Challenges and Opportunities for SynBio Companies

This article examines the impact of the democratization of computational design and discusses how synthetic biology companies must shift focus if they are to remain competitive.
RNA molecule.
Industry Insight

Quality Control for RNA Therapeutics: Meeting a Growing Need

New applications for RNA therapeutics are continuously emerging. In this burgeoning space, nucleic acid quantification can help this dynamic therapeutic modality reach its full potential.
Four drug tablets lined up.
Industry Insight

Data-Driven Adaptive Trials: Enhancing Safety, Accelerating Progress and Boosting Economics Through Enhanced Insights

Trial sponsors are faced with vast amounts of diverse data and corresponding endpoints spanning all trial sites linked to their study design. This article explores how interactive response technology can help sponsors overcome these challenges.
DNA helix.
Industry Insight

Exploring the Role of Viral Genomics in Pandemic Preparedness

This article discusses why the proactive detection and monitoring of viral threats through genomics studies is vital in preventing future pandemics and empowering healthcare providers in the face of increasing globalization.
A computer-generated image of a DNA double helix.
Industry Insight

Comprehensive Cancer Research Solutions: From Diagnostics to Therapy

At AACR 2023, Technology Networks spoke with Dr. Mark Garner, global cancer segment market manager at Agilent Technologies, to learn how the new SureSelect Cancer CGP assay is empowering the cancer research field.
A scientist holds a green globe in both hands. It is surrounded by icons representing areas of sustaibility.
Industry Insight

Ensuring Performance, Intelligence and Sustainability in MS

At ASMS, Technology Networks spoke with Ken Suzuki and Jennifer Gushue to learn more about how Agilent is addressing customer needs with novel “intelligence” features and the company’s efforts to ensure the sustainability and longevity of its products.
A large collection of different batteries
Industry Insight

The Challenges Facing Battery Manufacturers

Researchers have made significant strides toward developing improved battery chemistries, but scaling up production is challenging. To find out more, we spoke to Zhao Liu, senior market development manager at Thermo Fisher Scientific.
Advertisement